Antibodies from patients with psoriasis recognize N-acetylglucosamine terminals in glycoproteins from Pityrosporum ovale

I. Mathov, Lilian Plotkin, C. Abatangelo, R. Galimberti, L. Squiquera, J. L. Leoni

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We have previously reported the finding of circulating antibodies recognizing two proteins of 100 and 120kD (PO100 and PO120) from Pityrosporum ovale in patients with psoriasis. These antibodies were specific, since they were not detected in normal sera nor in other diseases linked to P. ovale such as seborrhoeic dermatitis or pityriasis versicolor. The present study aimed at further characterizing the specificity of these antibodies. Enzyme- labelled lectins were used to determine the carbohydrate composition of PO120 and PO100. BSII, a lectin that recognizes terminal N-acetylglucosamine (GlcNAc), showed the same banding pattern as sera from patients. Reactivity against these proteins was inhibited after mild oxidation of the carbohydrate moieties of the extract. Treatment of the extracts with lyticase altered the immune reactivity against the PO 120 band as seen in Western blot assays. PO100 was not detected after lyticase digestion. Digestion with lysozyme did not alter the immune reactivity of the PO100 and PO120 bands, although the protein pattern in SDS PAGE was modified. To examine the relevance of anti- GlcNAc antibodies in the immune response to P. ovale in psoriasis, we performed a binding inhibition ELISA. Psoriatic sera that were positive in the ELISA against a heat-denatured extract of P. ovale were rendered negative only by pre-incubation with GlcNAc in a concentration-dependent manner. Our results are indicative that the antibody response to PO100 and PO 120 in patients with psoriasis is directed towards terminal GlcNAc residues.

Original languageEnglish (US)
Pages (from-to)79-83
Number of pages5
JournalClinical and Experimental Immunology
Volume105
Issue number1
StatePublished - 1996
Externally publishedYes

Fingerprint

Malassezia
Acetylglucosamine
Psoriasis
Glycoproteins
Lectins
Antibodies
Digestion
Serum
Enzyme-Linked Immunosorbent Assay
Carbohydrates
Tinea Versicolor
Proteins
Antibody Specificity
Dermatitis
Muramidase
Antibody Formation
Polyacrylamide Gel Electrophoresis
Anti-Idiotypic Antibodies
Hot Temperature
Western Blotting

Keywords

  • lyticase
  • N-acetylglucosamine
  • Pityrosporum ovale
  • psoriasis

ASJC Scopus subject areas

  • Immunology

Cite this

Antibodies from patients with psoriasis recognize N-acetylglucosamine terminals in glycoproteins from Pityrosporum ovale. / Mathov, I.; Plotkin, Lilian; Abatangelo, C.; Galimberti, R.; Squiquera, L.; Leoni, J. L.

In: Clinical and Experimental Immunology, Vol. 105, No. 1, 1996, p. 79-83.

Research output: Contribution to journalArticle

Mathov, I. ; Plotkin, Lilian ; Abatangelo, C. ; Galimberti, R. ; Squiquera, L. ; Leoni, J. L. / Antibodies from patients with psoriasis recognize N-acetylglucosamine terminals in glycoproteins from Pityrosporum ovale. In: Clinical and Experimental Immunology. 1996 ; Vol. 105, No. 1. pp. 79-83.
@article{0d96226eb49844de9133edf718213fd2,
title = "Antibodies from patients with psoriasis recognize N-acetylglucosamine terminals in glycoproteins from Pityrosporum ovale",
abstract = "We have previously reported the finding of circulating antibodies recognizing two proteins of 100 and 120kD (PO100 and PO120) from Pityrosporum ovale in patients with psoriasis. These antibodies were specific, since they were not detected in normal sera nor in other diseases linked to P. ovale such as seborrhoeic dermatitis or pityriasis versicolor. The present study aimed at further characterizing the specificity of these antibodies. Enzyme- labelled lectins were used to determine the carbohydrate composition of PO120 and PO100. BSII, a lectin that recognizes terminal N-acetylglucosamine (GlcNAc), showed the same banding pattern as sera from patients. Reactivity against these proteins was inhibited after mild oxidation of the carbohydrate moieties of the extract. Treatment of the extracts with lyticase altered the immune reactivity against the PO 120 band as seen in Western blot assays. PO100 was not detected after lyticase digestion. Digestion with lysozyme did not alter the immune reactivity of the PO100 and PO120 bands, although the protein pattern in SDS PAGE was modified. To examine the relevance of anti- GlcNAc antibodies in the immune response to P. ovale in psoriasis, we performed a binding inhibition ELISA. Psoriatic sera that were positive in the ELISA against a heat-denatured extract of P. ovale were rendered negative only by pre-incubation with GlcNAc in a concentration-dependent manner. Our results are indicative that the antibody response to PO100 and PO 120 in patients with psoriasis is directed towards terminal GlcNAc residues.",
keywords = "lyticase, N-acetylglucosamine, Pityrosporum ovale, psoriasis",
author = "I. Mathov and Lilian Plotkin and C. Abatangelo and R. Galimberti and L. Squiquera and Leoni, {J. L.}",
year = "1996",
language = "English (US)",
volume = "105",
pages = "79--83",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Antibodies from patients with psoriasis recognize N-acetylglucosamine terminals in glycoproteins from Pityrosporum ovale

AU - Mathov, I.

AU - Plotkin, Lilian

AU - Abatangelo, C.

AU - Galimberti, R.

AU - Squiquera, L.

AU - Leoni, J. L.

PY - 1996

Y1 - 1996

N2 - We have previously reported the finding of circulating antibodies recognizing two proteins of 100 and 120kD (PO100 and PO120) from Pityrosporum ovale in patients with psoriasis. These antibodies were specific, since they were not detected in normal sera nor in other diseases linked to P. ovale such as seborrhoeic dermatitis or pityriasis versicolor. The present study aimed at further characterizing the specificity of these antibodies. Enzyme- labelled lectins were used to determine the carbohydrate composition of PO120 and PO100. BSII, a lectin that recognizes terminal N-acetylglucosamine (GlcNAc), showed the same banding pattern as sera from patients. Reactivity against these proteins was inhibited after mild oxidation of the carbohydrate moieties of the extract. Treatment of the extracts with lyticase altered the immune reactivity against the PO 120 band as seen in Western blot assays. PO100 was not detected after lyticase digestion. Digestion with lysozyme did not alter the immune reactivity of the PO100 and PO120 bands, although the protein pattern in SDS PAGE was modified. To examine the relevance of anti- GlcNAc antibodies in the immune response to P. ovale in psoriasis, we performed a binding inhibition ELISA. Psoriatic sera that were positive in the ELISA against a heat-denatured extract of P. ovale were rendered negative only by pre-incubation with GlcNAc in a concentration-dependent manner. Our results are indicative that the antibody response to PO100 and PO 120 in patients with psoriasis is directed towards terminal GlcNAc residues.

AB - We have previously reported the finding of circulating antibodies recognizing two proteins of 100 and 120kD (PO100 and PO120) from Pityrosporum ovale in patients with psoriasis. These antibodies were specific, since they were not detected in normal sera nor in other diseases linked to P. ovale such as seborrhoeic dermatitis or pityriasis versicolor. The present study aimed at further characterizing the specificity of these antibodies. Enzyme- labelled lectins were used to determine the carbohydrate composition of PO120 and PO100. BSII, a lectin that recognizes terminal N-acetylglucosamine (GlcNAc), showed the same banding pattern as sera from patients. Reactivity against these proteins was inhibited after mild oxidation of the carbohydrate moieties of the extract. Treatment of the extracts with lyticase altered the immune reactivity against the PO 120 band as seen in Western blot assays. PO100 was not detected after lyticase digestion. Digestion with lysozyme did not alter the immune reactivity of the PO100 and PO120 bands, although the protein pattern in SDS PAGE was modified. To examine the relevance of anti- GlcNAc antibodies in the immune response to P. ovale in psoriasis, we performed a binding inhibition ELISA. Psoriatic sera that were positive in the ELISA against a heat-denatured extract of P. ovale were rendered negative only by pre-incubation with GlcNAc in a concentration-dependent manner. Our results are indicative that the antibody response to PO100 and PO 120 in patients with psoriasis is directed towards terminal GlcNAc residues.

KW - lyticase

KW - N-acetylglucosamine

KW - Pityrosporum ovale

KW - psoriasis

UR - http://www.scopus.com/inward/record.url?scp=0030035964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030035964&partnerID=8YFLogxK

M3 - Article

C2 - 8697640

AN - SCOPUS:0030035964

VL - 105

SP - 79

EP - 83

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 1

ER -